Matrixyl® 3000 is a patented peptide complex composed of two biomimetic signal peptides: Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7. Available scientific data associate them with supporting natural mechanisms involved in maintaining skin structure.
Palmitoyl Tripeptide-1 is a peptide that mimics a collagen fragment (GHK sequence). According to available data, it supports the synthesis of collagen, fibronectin, and hyaluronic acid, essential components of the extracellular matrix, themselves linked to firmness and elasticity appearance of the skin.
Palmitoyl Tetrapeptide-7 complements this action. Available data associate it with modulating interleukin-6 production, a factor linked to visible signs of aging. This action is documented to help preserve skin structure integrity over time.
Clinical studies report, at 3% with twice-daily application over two months, the following results: 39.4% reduction in deep wrinkle surface area, 32.9% reduction in main wrinkle density, 19.9% reduction in average wrinkle depth, 16% improvement in roughness, 16.2% visible tightening effect, 5.5% improvement in elasticity, 15.5% improvement in skin tone evenness, with good documented skin tolerance. These results concern the ingredient alone and do not guarantee finished product results.
In summary, Matrixyl® 3000 is a reference anti-aging active associated with supporting skin structure and visible wrinkle reduction.